Cited by 111Hypothalamic control of reproductive hormonesHormonal and reproductive studiesAdrenal Hormones and Disorders

Dose-Dependent Effects of Recombinant Human Interleukin-6 on the Pituitary-Testicular Axis

Tsigos, Constantine, Papanicolaou, Dimitris A., Kyrou, Ioannis, Raptis, Sotirios A., Chrousos, George P.·1999·Journal of Interferon & Cytokine Research

Abstract

Inflammatory cytokines are soluble mediators of immune function that also regulate intermediate metabolism and several endocrine axes. To examine the effects of interleukin-6 (IL-6), the main circulating cytokine, on the hypothalamic-pituitary-testicular axis in men, we performed dose-response studies of recombinant human IL-6 (rHuIL-6) in normal volunteers. Increasing single doses of IL-6 (0.1, 0.3, 1.0, 3.0, and 10.0 microg/kg body weight) were injected subcutaneously into 15 healthy male volunteers (3 at each dose) in the morning. We measured the circulating levels of testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex hormone binding globulin (SHBG) at baseline and then at 24 h, 48 h, and 7 days after the IL-6 injection. LH and FSH levels were also measured half-hourly for the first 4 h after the IL-6 injection. All IL-6 doses were tolerated well and produced no significant adverse effects. Mean peak plasma IL-6 levels achieved after IL-6 administration were 8 +/- 1, 22 +/- 5, 65 +/- 22, 290 +/- 38, and 4050 +/- 149 pg/ml, respectively for the five doses. We observed no significant changes in plasma testosterone levels after the two smaller IL-6 doses. The three higher IL-6 doses, however, caused significant decreases in testosterone levels by 24 h, which persisted at 48 h and returned to baseline by 7 days. The higher testosterone suppression was after the 3.0 microg/kg dose, making the dose-response curve bell-shaped. There also appeared to be small but not significant increases in LH levels after the three higher IL-6 doses, which were not acute and seemed to follow temporally the testosterone decreases. The concurrent plasma levels of FSH and SHBG were not appreciably affected by any IL-6 dose. In conclusion, subcutaneous IL-6 administration, which caused acute elevations in circulating IL-6 levels of a similar magnitude to those observed in severe inflammatory and noninflammatory stress, induced prolonged suppression in testosterone levels in healthy men without apparent changes in gonadotropin levels. This suggests that IL-6 might induce persistent testicular resistance to LH action or suppression of Leydig cell steroidogenesis or both, with potential adverse effects on male reproductive function.

Integrity signals

Registry

Crossref · 10.1089/107999099312948

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In aging and chronic inflammatory diseases, the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction.

    “the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”
  • In aging and chronic inflammatory diseases, circulating cytokine levels can be 5 to 10 times higher than normal (e.g., IL-6 from 2 pg/ml to 10-20 pg/ml).

    “In these settings, circulating cytokine levels can be 5 to 10 times higher than normal (e.g., IL-6 from 2 pg/ml to 10–20 pg/ml), and the overall stimulus might be strong enough to induce a mild systemic water retention and energy appeal reaction (responses shown for low IL-6 serum concentrations in ref. [42, 43]).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Raptis, S. A., & Chrousos, G. P.
Affiliations
National Institutes of Health (US)
Venue
Journal of Interferon & Cytokine Research
Published
1999-11
Volume
19
Issue
11
Pages
1271-1276
ISSN
  • 1079-9907 (ISSN-L)
  • 1557-7465
OpenAlex
W2015294286
Cited by
111
References
31
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 9 · 2016: 1 · 2015: 9 · 2014: 4 · 2013: 3 · 2012: 5
FWCI
2.06
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Interferon & Cytokine Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
interleukin-6, hypothalamic-pituitary-testicular axis, testosterone suppression, luteinizing hormone, follicle-stimulating hormone, sex hormone-binding globulin, Leydig cell steroidogenesis, dose-response relationship, inflammatory cytokines, gonadotropin secretion, male reproductive endocrinology, healthy men, subcutaneous injection
MeSH terms
Adult, Dose-Response Relationship, Drug, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Male, Pituitary Gland, Recombinant Proteins, Reference Values, Sex Hormone-Binding Globulin, Testis, Testosterone, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review